Abstract. The effects of intrahepatic cholestasis of pregnancy (ICP) on hepatic function, changes of inflammatory cytokines and fetal outcomes were studied. In total, 663 pregnant women admitted to Daqing Longnan Hospital from July 2016 to December 2017 were selected. There were, 40 cases with ICP enrolled in the observation group, and 40 normal pregnant women were recruited in the normal group. They were also grouped according to hepatic function and inflammatory cytokines, with 40 cases in each group. Neonatal Apgar scores were recorded. The correlations of serum cholylglycine (CG) in pregnant women with umbilical artery systolic-to-diastolic (S/D) ratio in the third trimester of pregnancy, the alanine aminotransferase level, the high-sensitivity C-reactive protein (hs-CRP) level, neonatal Apgar score and gestational week were analyzed. The birth weight in the observation group was lighter than that in the normal group (P<0.05); the gestational week at birth was earlier than that in the normal group (P<0.05); Apgar score at birth was lower than that in the normal group (P<0.05), and the levels of inflammatory cytokines were higher than those in the control group (P<0.05). Apgar scores of newborns at birth and at 1 and 5 min after birth in the normal hepatic function and normal inflammatory cytokine groups were higher than those in the abnormal hepatic function group (P<0.05). The serum CG level in pregnant women was positively correlated with umbilical artery S/D ratio, the alanine aminotransferase level and the hs-CRP level in the third trimester of pregnancy, but negatively correlated with neonatal Apgar score and gestational week. Among patients with ICP, the higher the GG level in the body is, the higher the alanine aminotransferase, inflammatory cytokine and umbilical artery S/D ratio will be, which may cause lower neonatal Apgar score, neonatal asphyxia and premature delivery.
Introduction
Intrahepatic cholestasis of pregnancy (ICP) is a specific disease during pregnancy, its clinical manifestations include cutaneous pruritus, formation of jaundice and abnormal hepatic function (1) . The causes of the disease are not quite clear yet, but this syndrome may severely threaten fetal growth and development, result in intrauterine fetal distress and even intrauterine death, and cause premature delivery, neonatal hypoxia-ischemia and asphyxia (2) . Most scholars consider that the pathogenesis of this disease is notably correlated with maternal bile acid level, especially the CG level in the body of pregnant women (3) . Long-term high bile acid level, especially high CG level will cause significant spasm in vessels on the surface of placental villi (4) , and the increased resistance caused by it will lead to reduced blood flow passing through the area of placenta intervillous space and decreased oxygenation (4) , and further bring about insufficient fetal perfusion (5) , functional hypoxia-ischemia, difficulty in transshipment of oxygen molecules and nutrient substance from maternal circulation. This will finally result in intrauterine fetal distress and affect growth and development of fetuses (6) .
Currently, the treatment for ICP is mainly symptomatic support measures. Fetal development condition is closely monitored, and manual intervention is implemented to terminate pregnancy (7) . Its primary mechanism is that long-term high bile acid level, especially high CG level, affects the growth and development of fetuses and may even result in intrauterine fetal distress (8) . Although there are many studies on ICP, there are few systematic correlation studies on effects of ICP on hepatic function, changes in the inflammatory cytokine level in the body of pregnant women and fetal outcomes. In order to better answer the national fundamental policy of better prenatal and postnatal care, enhance pregnancy outcomes and improve safety of pregnant and lying-in women and newborns during the perinatal period, this investigation mainly evaluated the deficiencies mentioned above, so as to better guide clinical treatment and improve neonatal outcomes. (9) , there were 40 patients diagnosed with ICP, all of whom suffered from no liver-, gall-or skin-related diseases before pregnancy. After the second and third trimesters of pregnancy, ICP was manifested as significant and persistent pruritus, which often occurred in the proximal hands, feet and limbs, and even mild jaundice was seen. Increased serum cholic acids were found in the biochemical examination. In particular, the index of serum cholylglycine (CG) was more than 30 mg/l, and a mild to moderate increase could be found in bilirubin. The above symptoms and signs returned to normal after pregnancy.
Effects of intrahepatic cholestasis of pregnancy on hepatic function, changes of inflammatory cytokines and fetal outcomes
All the patients and their family members signed the inclusion consent, and this study was approved by the Ethics Committee of the Daqing Longnan Hospital. These patients were aged 19-40 years with an average of 29.5±0.3 years. Times of pregnancy: 25 cases of primiparity, 15 cases of re-pregnancy and 10 cases who had previously undergone cesarean section. Additionally, 40 patients with normal pregnancy aged 19-40 years with a mean age of 29.6±0.3 years were selected as the normal group. Times of pregnancy: 26 cases of primiparity, 14 cases of re-pregnancy and 9 cases who had previously undergone cesarean section. There were no statistically significant differences in age, times of pregnancy and whether they had received previous cesarean section between the two groups (P>0.05). Comparisons of birth weight, gestational week at birth, Apgar score at birth, grade II or above amniotic fluid contamination, intrauterine fetal distress and neonatal jaundice between the two groups are detailed in Table I . All the included patients were divided into two groups according to whether their hepatic function was normal or not. Among them, 40 patients with normal hepatic function aged 19-40 years with a mean age of 29.4±0.3 years were included into the normal hepatic function group. Times of pregnancy: 26 cases of primiparity, 14 cases of re-pregnancy and 11 cases who had previously received cesarean section. Forty patients with abnormal hepatic function aged 19-40 years with an average age of 29.4±0.4 years were included into the abnormal hepatic function group. Times of pregnancy: 27 cases of primiparity, 13 cases of re-pregnancy and 12 cases who previously had received cesarean section.
Differences in age, times of pregnancy and a history of implementation of cesarean section between the two groups were not statistically significant (P>0.05). In addition, according to whether inflammatory cytokines [with high-sensitivity C-reactive protein (hs-CRP) as the standard] were increased, the patients were divided into two groups. There were 40 patients with normal inflammatory cytokines aged 19-40 years with an average of 29.5±0.5 years included in the normal inflammatory cytokine group. Times of pregnancy: 28 cases of primiparity, 12 cases of re-pregnancy and 12 cases who had previously received cesarean section. Forty patients with abnormal inflammatory cytokines aged 19-40 years with an average age of 29.6±0.5 years were included into the abnormal inflammatory cytokine group. Times of pregnancy: 29 cases of primiparity, 11 cases of re-pregnancy and 13 cases who had previously received cesarean section. There were no statistically significant differences in age, times of pregnancy and implementation rate of cesarean section between the two groups (P>0.05).
Intervention methods. All the included patients were given low-flow oxygen, local antipruritic or corticosteroid treatment. Reduction of the concentration of bile acids (ursodeoxycholic acid), vitamin K supplement, vascular dilation, liver protection and other symptomatic support treatments. Regular fetal heart rate monitoring and amniotic fluid index test were carried out. In addition, the levels of bile acid and serum CG in pregnant women and hepatic function of patients were regularly reviewed. Fetal lung maturation was closely monitored, and if necessary, cesarean section was implemented to terminate pregnancy based on the patient's CG level combined with fetal monitoring results. The normal control group was treated with routine pregnancy and delivery.
Observational indexes. The relevant data of newborns such as birth weight, gestational week at birth and Apgar score at birth, intrauterine and postpartum conditions such as the occurrence of grade II or above amniotic fluid contamination, intrauterine fetal distress and the proportion of neonatal jaundice, the levels of inflammation-related cytokines such as hs-CRP, interleukin-6 (IL-6) and tumor necrosis factoralpha (TNF-α), and Apgar scores at birth, and at 1 and 5 min after birth of newborns delivered by patients with different hepatic functions and different inflammatory cytokine levels were compared between the observation and control groups. The correlation of the level of CG in pregnant women with umbilical artery systolic-to-diastolic (S/D) ratio in the third trimester of pregnancy during antenatal inspection, the alanine aminotransferase level, the hs-CRP level, neonatal Apgar score and gestational week were analyzed.
Evaluation criteria. Apgar score: Apgar score of newborns at birth was assessed in this study. The evaluation criteria included five items: skin color, heart rate pulse, respiratory rate, muscular tone and motor ability, and nerve reflex. The overall score ranged from 0 to 10 points. The total score below 21 .0 (IBM Corp., Armonk, NY, USA) was adopted for statistical analysis. Measurement data were expressed as mean ± standard deviation (mean ± SD). The mean values, such as birth weight, gestational week and Apgar score at birth, were compared using the t-test. The percentages, such as grade II or above, amniotic fluid contamination, intrauterine fetal distress and neonatal jaundice percentages were compared between groups using the χ 2 test. Spearman's correlation analyses of the serum CG level with umbilical artery S/D ratio in the third trimester of pregnancy during antenatal inspection, the level of alanine aminotransferase, the level of hs-CRP, neonatal Apgar score and gestational week were performed using the correlation coefficient method. P<0.05 was set as the statistically significant difference.
Results

Comparison of relevant data between the groups of newborns.
The birth weight of the observation group was lighter than that of the normal group (P<0.05), the gestational week at birth was earlier than that of the normal group (P<0.05), and Apgar score at birth was lower than that of the normal group (P<0.05) ( Table I) .
Comparison of intrauterine and postpartum conditions between the groups.
The proportions of grade II or above amniotic fluid contamination, intrauterine fetal distress and neonatal jaundice in the observation group were significantly higher than those in the normal group (P<0.05) ( Table II) .
Comparison of the levels of inflammation-related cytokines between the groups.
The levels of hs-CRP, IL-6 and TNF-α among the inflammation-related cytokines in the observation group detected at the time of inclusion were notably higher than those in the control group (P<0.05) (Table III) .
Changes in Apgar scores of newborns with different hepatic functions.
Apgar scores of newborns at birth and at 1 and 5 min after birth in the normal hepatic function group were evidently higher than those in the abnormal hepatic function group (P<0.05) (Table IV) .
Changes in Apgar scores of newborns with different levels of inflammatory cytokines.
Apgar scores of newborns at birth and at 1 and 5 min after birth in the normal inflammatory cytokine group were higher than those in the abnormal inflammatory cytokine group (P<0.05) ( Table V) .
Correlation analyses of the serum CG level with umbilical artery S/D ratio values in the third trimester of pregnancy during antenatal inspection, the level of alanine aminotransferase, the level of hs-CRP, neonatal Apgar score and gestational week.
The level of serum CG in pregnant women with ICP was positively correlated with umbilical artery S/D ratio in the third trimester of pregnancy during antenatal inspection (r= 0.8508, P<0.001) (Fig. 1) , the level of alanine aminotransferase (r=0.9458, P<0.001) (Fig. 2 ) and the level of hs-CRP (r=0.9329, P<0.001) (Fig. 3) , but negatively related to neonatal Apgar score (r=-0.8855, P<0.001) (Fig. 4) and gestational week (r=-0.8924, P<0.001) (Fig. 5) .
Discussion
ICP is a distinctive disease in the second and third trimesters of pregnancy, mainly manifested as pruritus, jaundice and abnormal hepatic function (10) . A previous study (11) indicated that the high-level estrogen for a long term during pregnancy leads to excessive bile formation and acatharsia (12) . Besides, selenium deficiency during pregnancy, ATP8B1 gene defects in pregnant women and positive cytochrome P450 1A2 (CYPIA2), an estrogen metabolism gene, are related factors contributing to ICP (13) . ICP is harmful to the fetus and has a great adverse effect on the perinatal prognosis. The maternal cholestasis leads to abnormal liver function, which in turn leads to the decrease of normal endocrine function and toxin degradation ability of the liver (14) . Over time, maternal bile acids and toxins are transferred to the fetus via placental circulation, leading to premature delivery, intrauterine distress and even fetal asphyxia (15) . For the diagnosis and treatment of ICP during pregnancy, serum CG has the highest specificity, which can provide a better guidance for the clinical treatment. This study explored the effects of the level of serum CG in patients with ICP on hepatic function, inflammatory cytokines and fetal outcomes. In the present study, all patients with cholestasis of pregnancy were treated with general prescription for ICP. Related conditions of newborns were compared between the two groups, and it was found, respectively, that birth weight, gestational week at birth and Apgar score at birth in the observation group were lighter, earlier and lower than those in the normal group, indicating that newborns delivered by these patients with ICP have lighter weight, earlier gestational week and lower birth Apgar scores. Additionally, comparisons of intrauterine and postpartum conditions between the two groups revealed that the incidence rates of grade II or above amniotic fluid contamination, intrauterine fetal distress and neonatal jaundice in the observation group were significantly higher than those in the normal group, further suggesting that the incidence rates of amniotic fluid contamination, intrauterine fetal distress and neonatal jaundice are obviously increased in patients with ICP.
Comparison of the levels of inflammation-related cytokines between the two groups manifested that the levels of hs-CRP, IL-6, and TNF-α among the inflammation-related cytokines in the observation group detected at the time of inclusion were markedly higher than those in the control group, indicating that the levels of inflammatory cytokines in patients with normal hepatic function are significantly lower than those in patients with abnormal hepatic function. In addition, the study on changes in Apgar scores of newborns delivered by patients with different hepatic functions and different inflammatory cytokine levels demonstrated that Apgar scores of newborns at birth and at 1 min and 5 min after birth in the normal hepatic function and normal inflammatory cytokine groups were higher than those in the abnormal hepatic function group. This suggests that the hepatic function and the in vivo inflammatory cytokine level of pregnant women are associated with neonatal Apgar score to some extent. Finally, the correlation analyses of the serum CG level in pregnant women with umbilical artery S/D ratio in the third trimester of pregnancy during antenatal inspection, the level of alanine aminotransferase, the level of hs-CRP, neonatal Apgar score and gestational week illustrated that the serum CG level in pregnant women was positively correlated with umbilical artery S/D ratio in the third trimester of pregnancy during antenatal inspection, the level of alanine aminotransferase and the level of hs-CRP, but negatively related to neonatal Apgar score and gestational week.
The high-level cholic acid, especially high CG, in pregnant women with ICP, may cause the shrinkage of the placental villus (16), thus, resulting in edema of the placental trophocytes. Despite the increased number, edema occurs in the basal villus, and the villous cavity remarkably declines (17) , thus causing a significant reduction of maternal blood flow in the placental villus cavity, fetal hypoxia and intrauterine distress (18) . ICP in the body evidently stimulates fetal intestinal peristalsis to be enhanced (19) , resulting in meconium-stained amniotic fluid, neonatal asphyxia and lowered neonatal Apgar score, so the proportions of contaminated amniotic fluid and intrauterine fetal distress in patients with ICP are increased. It was also verified in this study that the serum CG level in pregnant women was positively correlated with the level of alanine aminotransferase in hepatic function of pregnant women with ICP, umbilical artery S/D ratio in the third trimester of pregnancy and the level of hs-CRP, but negatively related to neonatal Apgar score and gestational week. With the development of pregnancy, the placental circulatory resistance decreased, the end-diastolic blood flow rate accelerated, the umbilical blood flow resistance decreased, and the umbilical blood flow increased. However, in pregnant women with ICP, the number of arterioles in the third grade villous trunk of placenta decreased significantly, resulting in the obstruction of material exchange between fetus and mother through the umbilical cord, and the increase of S/D value. Then the placental dysfunction affects the development of the fetus. In addition, neonatal jaundice mainly caused hypermetabolism of fetal hemoglobin catabolism due to intrauterine hypercholidemia and liver cell injury. After birth, microsomal and glucuronic acid binding disorder occurred in hepatocytes. Thus, the ability of bilirubin to decompose is reduced, and jaundice occurs in newborns (20) . There was a positive correlation between serum cholic acid level and hs-CRP level in pregnant women with ICP. The increase of inflammatory cytokines in the body may lead to the increase of mitochondria and neutrophils, the increase of oxygen free radicals, the damage of lipid peroxidation and the increase of the level of immunological cytokines, which further aggravates the damage of liver function. It may also promote the production of a large amount of estrogen in the placenta, leading to the imbalance of estrogen and progesterone levels in the mother and placenta, further exacerbating ICP and increasing the level of serum glycine cholic acid (21).
In conclusion, in patients with ICP, as the level of CG in the body is increased, the levels of alanine aminotransferase and hs-CRP in pregnant women and umbilical artery S/D ratio are significantly increased. Moreover, this leads to lower Apgar score of newborns, neonatal asphyxia, shortened gestational week and premature birth.
